PTEN (Phosphatase and Tensin homolog) loss-of-function derepresses PI3K–AKT–mTOR signaling and impairs DNA-damage responses, promoting LUAD/NSCLC; mutations or silencing that reduce PTEN activity are the key changes. Here, PTEN is linked to non-small cell lung carcinoma.